Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 50 Lung Neoplasms 25 Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Neoplasm Metastasis 6 Colorectal Neoplasms 5 Pancreatic Neoplasms 4 Mesothelioma, Malignant 3 Melanoma 3 Colonic Neoplasms 3 Carcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Non-squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 Mesothelioma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Adenocarcinoma of Lung 2 Vaccinia 1 Uterine Cervical Neoplasms 1 Thoracic Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Respiratory Tract Neoplasms 1

Interventions

pembrolizumab 1 Pemetrexed 1 Cisplatin 1 Carboplatin 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Non-small Cell Lung Cancer × Pemetrexed × 30 days × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡